Tyche Industries Limited (BOM:532384)
India · Delayed Price · Currency is INR 104.00
+0.90 (0.87%)
At close: Aug 21, 2026
Tyche Industries Revenue
Tyche Industries had revenue of 90.99M INR in the quarter ending June 30, 2026, a decrease of -28.35%. This brings the company's revenue in the last twelve months to 500.33M, down -20.14% year-over-year. In the fiscal year ending March 31, 2026, Tyche Industries had annual revenue of 536.34M, down -19.01%.
Revenue (ttm)
500.33M
Revenue Growth
-20.14%
P/S Ratio
2.13
Revenue / Employee
3.09M
Employees
162
Market Cap
1.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 536.34M | -125.87M | -19.01% |
| Mar 31, 2025 | 662.22M | -34.63M | -4.97% |
| Mar 31, 2024 | 696.84M | -59.16M | -7.83% |
| Mar 31, 2023 | 756.00M | 125.84M | 19.97% |
| Mar 31, 2022 | 630.16M | -163.86M | -20.64% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.15B |
| Smruthi Organics | 1.12B |
| Kimia Biosciences | 1.12B |
| Panchsheel Organics | 1.08B |
| Resonance Specialties | 1.02B |
| Auro Laboratories | 364.26M |
| Vasundhara Rasayans | 347.79M |
| Crestchem | 338.33M |